It Takes an Iron Stomach to Invest in Biotech Stocks
Insights - That was apparent yet again this week, with a slew of binary events that moved stocks in unexpected ways. Beginning with Zafgen (ZFGN). The developer … Continue Reading
Read NowRecap
Biotech Had a Compelling, Late-Week Rally
Insights - The iShares NASDAQ Biotech ETF (IBB) posted a major reversal from lows this Monday to close the week slightly in the green. That rally, most … Continue Reading
Read Now
Let’s List All of the Events Impacting Sentiment for Equities…
Insights - The NASDAQ Biotech Index (NBI) ended the week on a low note – just 2 percentage points from giving back the entirety of its gains … Continue Reading
Read NowA Roundup of this Week’s Market/Biotech Events
Insights - The long-awaited September meeting of the FOMC takes place this coming Thursday. Market participants are unusually attuned to this particular meeting due to the ongoing … Continue Reading
Read NowHere’s a Deal for Your Three-Day Weekend…
Insights - After the last two weeks, everyone’s ready for a 3-day break. August closed out with the S&P 500 down 6%, and the NASDAQ Biotech Index … Continue Reading
Read NowMight Ariad Pharma Finally be Bought?
Insights - That was the rumor on anyway, sending shares of Ariad Pharmaceuticals (ARIA) higher by 40% in the Friday trading session. Bloomberg reported at noon on … Continue Reading
Read NowBiopharma Investors Are In A Funny Spot
Insights - Biopharma investors are in a funny spot. Where small/mid-cap biotech and pharma stocks have been pulling back for over a month now, the broader markets … Continue Reading
Read Now